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Editor, Malignancy can arise in pleomorphic adenoma (PA) in the form of carcinoma ex PA (CEPA), carcinosarcoma, or metastasizing PA (MPA), with MPA accounting for 1% of malignant PA. [1] MPA is histologically benign and yet exhibits malignant behavior in the form of metastasis.
A 38-year-old male presented with a history of persistent loin pain and hematuria of 3-month duration. Ultrasonogram was suspicious of left renal hematoma. Contrast-enhanced computed tomography scan revealed a large enhancing lesion involving the left kidney, suggestive of malignancy [ Figure 1a ]. A left radical nephrectomy was done with a presumptive diagnosis of renal cell carcinoma.
Gross specimen showed a large whitish, circumscribed, solid mass in the kidney [ Figure 1b ]. Microscopic examination showed features of a benign biphasic neoplasm mimicking PA [ Figure 1c ]. Atypical mitosis, anaplasia, or lymphovascular emboli were not seen. Suspecting a nonrenal tumor, the patient's history was sought for which was significant for a parotidectomy 21 years before the current presentation. He had two recurrences at 8 years (2003) and 18 years (2013) following the initial surgery. On reviewing the slides of the parotidectomy specimen in 2013, histology was consistent with benign PA [ Figure 1d ], and the excision was incomplete. Immunohistochemically, tumor cells expressed CK-7 (epithelial cells), p63 (myoepithelial cells), S-100 (myoepithelial cells and cells of chondromyxoid matrix) and very low MIB-1 (Ki-67)-labeling index (<1%) [ Figure 1e -h]. A final diagnosis of benign MPA was offered. The patient is on follow-up and asymptomatic.
MPA is a very rare tumor with only 84 cases described in English literature from 1942 to 2016, of which 8 are in the kidney. [2] There is a slight female predilection for MPA and the age at diagnosis ranges from 11 to 83 years (mean age at diagnosis 49.5 years) with the mean time interval between PA and MPA being 14.9 years (range 0-51 years). [2] Most common sites of metastasis are bone, lung, and lymph nodes. [2] The other less common sites of MPA are liver, thyroid, retroperitoneum, brain, and kidney. [3, 4] The sites of primary PA include parotid gland, submandibular gland, minor salivary glands (palate, nasal septum, and tongue), and lung. [5] Histologically, the primary salivary gland tumor and metastases are composed of the typical mixture of benign-appearing epithelial and mesenchymal components of PA. Predictable morphological features of metastasizing tumors such as cellular atypia and mitosis are not known to occur in MPA. Immunohistochemically, our case showed p63 and S100 positivity suggestive of retained myoepithelial differentiation in the tumor cells, excluding CEPA. [3] Furthermore, CK-7 was strongly positive in epithelial elements and Ki-67 proliferation index was very low supporting benign histology.
The mortality rate of MPA is approximately 20%. [5] Development of metastasis within the first 10 years after the initial surgery and the presence of metastases in multiple sites are independent predictors of poor survival. In patients with recurrent PA, a careful 
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